Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aclaris Therapeutics, Inc. - Common Stock (NQ:ACRS)

1.910 +0.040 (+2.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 920,247
Open 1.910
Bid (Size) 1.900 (2)
Ask (Size) 1.950 (1)
Prev. Close 1.870
Today's Range 1.880 - 1.950
52wk Range 1.050 - 5.170
Shares Outstanding 107,850,124
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Market Today: US Future Edge Higher Ahead Of FOMC Decision—Meta, Microsoft Earnings In Focus
U.S. stock futures rose on Wednesday after ending lower on Tuesday. Futures of major benchmark indices were slightly higher. 
Via Benzinga
Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement
Aclaris Therapeutics Inc (NASDAQ: ACRS) surgged 21.94% in after-hours trading on Tuesday after positive top-line results from its open-label Phase 2a trial. 
Via Benzinga

Performance

YTD
-23.0%
-23.0%
1 Month
-2.1%
-2.1%
3 Month
+20.9%
+20.9%
6 Month
+61.9%
+61.9%
1 Year
+59.2%
+59.2%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
Aclaris Therapeutics: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Aclaris Stock Rises As Analyst Projects Billions In Sales For New Therapy
Via Benzinga
Santa Rally, January Effect, And Top Stock Picks
Via Talk Markets
Topics Stocks / Equities
This Weyerhaeuser Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
Via Benzinga
Level Up Your Trading: Inside The 4-Pillar Strategy Behind Triple-Digit Returns
Via Talk Markets
Topics Stocks / Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
Via Benzinga
War, Gold, And Opportunity: Uncovering Today’s Market Moves
Via Talk Markets
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Aclaris Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Via MarketBeat
Aclaris Therapeutics And 1 Other Stock Under $5 Insiders Are Buying
Via Benzinga
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
ACRS Stock Earnings: Aclaris Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
Via FinancialNewsMedia
Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Aclaris Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aclaris Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aclaris Therapeutics, Inc. - Common Stock trade on?
Aclaris Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aclaris Therapeutics, Inc. - Common Stock?
The ticker symbol for Aclaris Therapeutics, Inc. - Common Stock is ACRS on the Nasdaq Stock Market
What is the current price of Aclaris Therapeutics, Inc. - Common Stock?
The current price of Aclaris Therapeutics, Inc. - Common Stock is 1.910
When was Aclaris Therapeutics, Inc. - Common Stock last traded?
The last trade of Aclaris Therapeutics, Inc. - Common Stock was at 10/13/25 04:00 PM ET
What is the market capitalization of Aclaris Therapeutics, Inc. - Common Stock?
The market capitalization of Aclaris Therapeutics, Inc. - Common Stock is 205.99M
How many shares of Aclaris Therapeutics, Inc. - Common Stock are outstanding?
Aclaris Therapeutics, Inc. - Common Stock has 206M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.